Courage Capital Management Llc decreased its stake in Conatus Pharmaceuticals (CNAT) by 38.25% based on its latest 2018Q3 regulatory filing with the SEC.
Sunday, 13 January 2019
Conatus Pharmaceuticals (CNAT) Shares Declined While Courage Capital Management Trimmed Holding by $464,750; Assured Guaranty (AGO) Shareholder Kahn Brothers Group Has Lifted Its Stake by $563.35 Million as Stock Value Declined - The FinReviewer
Conatus Pharmaceuticals (CNAT) Shares Declined While Courage Capital Management Trimmed Holding by $464,750; Assured Guaranty (AGO) Shareholder Kahn Brothers Group Has Lifted Its Stake by $563.35 Million as Stock Value Declined The FinReviewer
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment